We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Roche and Isis Pharmaceuticals Form Alliance for Huntington's Disease

News   Apr 10, 2013

 
Roche and Isis Pharmaceuticals Form Alliance for Huntington's Disease
 
 
Advertisement
 

RELATED ARTICLES

Researchers Cultivate Mini Lungs for SARS-CoV-2 Research

News

A Bochum-based team intends to use organoids derived from stem cells to study the progression of SARS-CoV-2 infection and to identify antiviral substances.

READ MORE

FDA Grants Fast Track Designation to Onvansertib for Second-line Treatment of KRAS-mutated Colorectal Cancer

News

The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to onvansertib, an oral and highly-selective Polo-like Kinase 1 (PLK1) inhibitor, for the second-line treatment of patients with KRAS-mutated metastatic colorectal cancer.

READ MORE

Solving the Medical Mystery of Anesthesia

News

Researchers have solved the longstanding mystery of the mechanisms behind the effects of anesthetics.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE